Placenta-derived mesenchymal stem cells for prenatal myelomeningocele repair: promise, pitfalls, and unanswered questions after phase I of the CuRe trial.
- DOI
- 10.21037/atm-2026-0115
- Published
- 2026 Oct 30
- Container
- Annals of translational medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.21037/atm-2026-0115,
title = {Placenta-derived mesenchymal stem cells for prenatal myelomeningocele repair: promise, pitfalls, and unanswered questions after phase I of the CuRe trial.},
author = {Al-Haddad S and Munoz JL},
year = {2026},
journal = {Annals of translational medicine},
doi = {10.21037/atm-2026-0115},
url = {https://doi.org/10.21037/atm-2026-0115}
}RIS
TY - JOUR TI - Placenta-derived mesenchymal stem cells for prenatal myelomeningocele repair: promise, pitfalls, and unanswered questions after phase I of the CuRe trial. AU - Al-Haddad S AU - Munoz JL PY - 2026 JO - Annals of translational medicine DO - 10.21037/atm-2026-0115 UR - https://doi.org/10.21037/atm-2026-0115 ER -
APA
S, A., & JL, M. (2026). Placenta-derived mesenchymal stem cells for prenatal myelomeningocele repair: promise, pitfalls, and unanswered questions after phase I of the CuRe trial.. Annals of translational medicine. https://doi.org/10.21037/atm-2026-0115
Source records
- pubmed · retrieved 2026-11-10T11:00:59.228Z